ARCHIVES

Public Interest Representatives Says Clearinghouse Delayed TRIS Action; Brown Refutes Charge

This article is from The Cancer Letter archive.

Vol. 04 No. 10 | March 10, 1978

Download PDF Visit The Full Archive

Related Articles

Treatment IND or GM-CSF Is Approved

October 5, 1990

Nevins: Duke Administration Did a “Very Good Job” Of Handling The Crisis

April 1, 2011

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

February 16, 2007

In Brief: Hammer Hears A Claim for The $1 Million Wynder’s Theory On Japan’s Colon Cancer Rates: Hamburgers

March 19, 1982

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

New Awards for New Investigators To Replace R-23 Grants

November 8, 1985